Bone morphogenetic protein 10 and atrial fibrillation

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Genetic Epidemiology

Background:

• Observational studies suggest a link between bone morphogenetic protein 10 (BMP10) and atrial fibrillation (AF), but causal relationships remain unclear.
• Existing research on BMP10 and AF relies on observational data, necessitating robust methods to establish causality.

Purpose of the Study:

• To evaluate the potential causal effect of BMP10 on the risk of developing atrial fibrillation (AF).
• To leverage Mendelian randomization (MR) to assess genetic associations between BMP10 and AF risk.

Main Methods:

• A Mendelian randomization (MR) framework was employed using genome-wide association study (GWAS) data for BMP10 and AF.
• Genetic variants associated with BMP10 were identified from large-scale GWAS datasets of European ancestry.
• Multiple statistical methods (IVW, MR-Egger, weighted median) were used to analyze the association, with pleiotropy and sensitivity analyses performed.

Main Results:

• No statistically significant causal association was found between BMP10 and atrial fibrillation (AF) across various MR methods.
• Analyses revealed no significant horizontal pleiotropy, indicating the reliability of the genetic instruments used.
• Sensitivity analyses confirmed the robustness of the findings, showing no fundamental impact from potential biases.

Conclusions:

• This large-scale genetic study indicates a plausible non-causal association between BMP10 and AF in European populations.
• The findings challenge a direct causal role for BMP10 in AF pathogenesis based on current genetic evidence.
• Further research incorporating diverse ancestral populations is recommended to confirm these genetic associations.